SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 38.27 |
| Enterprise Value ($M) | 23.57 |
| Book Value ($M) | 57.09 |
| Book Value / Share | 1.04 |
| Price / Book | 0.67 |
| NCAV ($M) | 47.40 |
| NCAV / Share | 0.87 |
| Price / NCAV | 0.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.18 |
| Return on Assets (ROA) | -0.77 |
| Return on Equity (ROE) | -0.87 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.43 |
| Current Ratio | 4.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 116.16 |
| Assets | 125.84 |
| Liabilities | 68.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 20.97 |
| Operating Income | -121.50 |
| Net Income | -118.51 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic And Diluted Calculated On Quarterly Basis | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -92.08 |
| Cash from Investing | 43.46 |
| Cash from Financing | 38.15 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bain Capital Life Sciences Opportunities III, LP | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 4.83 | -15.17 | |
| 13G/A | BlackRock Inc. | 6.50 | -3.99 | |
| 13G/A | Vifor (International) Ltd | 13.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,164 | 150,097 | 15.43 | |
| 84,521 | 283,380 | 29.83 | |
| 70,032 | 42,394 | 165.19 | |
| 83,973 | 31,476 | 266.78 | |
| 101,549 | 54,570 | 186.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BIOR – Biora Therapeutics, Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. | CARM – Carisma Therapeutics, Inc. |
| CGTX – Cognition Therapeutics, Inc. |